Chris MacDonald

Chris MacDonald

InvestorPlace Contributor

Chris MacDonald is an MBA (finance) graduate with extensive experience covering small-, mid- and large-cap companies in the U.S. and Canadian markets. Chris is interesting in uncovering long-term and deep-value opportunities for investors based on principles from the Graham-Buffett school of thought, and looks forward to bringing investors a unique fundamental-based perspective on opportunities available in today’s challenging investing environment.

His experience as a financial analyst in the past, coupled with his fervor for finding undervalued growth opportunities, contribute to his conservative, long-term investing perspective.

Recent Articles

Fuel Cell Stocks Alert: What Is Going on With PLUG and FCEL Stocks Today?

By Chris MacDonald, InvestorPlace Contributor

Over the weekend, the House of Representatives passed the infrastructure bill. Now fuel cell stocks finally have a positive catalyst.

Cannabis Stocks: Why TLRY, CRON, ACB, SNDL Stocks Are Getting High Today

By Chris MacDonald, InvestorPlace Contributor

Today, news of what could potentially be a big legislative win, as well as the recent infrastructure bill news, is boosting cannabis stocks.

QS Stock: 2 Big Reasons QuantumScape Is Surging Higher Today

By Chris MacDonald, InvestorPlace Contributor

Today, investors in QuantumScape are cheering two key catalysts that investors hope will take QS stock on a fantastic ride.

CGC Stock Alert: What Is Going on With Canopy Growth Today?

By Chris MacDonald, InvestorPlace Contributor

Today's earnings report for Canopy Growth Corp. has sent shares of CGC stock plummeting as investors avoid the cannabis sector altogether.

Shake Shack Price Predictions: Why One Analyst Sees SHAK Stock Roaring to $100

By Chris MacDonald, InvestorPlace Contributor

Today, various Shake Shack price predictions have created a rather bullish environment for SHAK stock, which has surged on heavy volume.

DCPH Stock Alert: Why Is Deciphera Pharmaceuticals Plunging 70%?

By Chris MacDonald, InvestorPlace Contributor

Today, investors in Deciphera Pharmaceuticals and DCPH stock have seen tremendous selling pressure take this stock to all-time lows.

ALZN Stock: Why Is Little-Known Alzamend Neuro Gaining Today?

By Chris MacDonald, InvestorPlace Contributor

Today, investors in preclinical biotech company Alzamend Neuro and ALZN stock are seeing impressive gains of more than 25% currently.

WKHS Stock Plunges Because Workhorse Is Under a Second Investigation

By Chris MacDonald, InvestorPlace Contributor

Today, a new Department of Justice probe into Workhorse has sent shares of WKHS stock tumbling 10% in earlier trading on obvious concerns.

LCID Stock Alert: What Is Going on With Lucid Motors Today?

By Chris MacDonald, InvestorPlace Contributor

Here are a couple of key news items that appear to be driving a tremendous amount of interest in Lucid Group and LCID stock today.

7 Safe Stocks that are Immune from China’s Market Volatility

By Chris MacDonald, InvestorPlace Contributor

Those worried about what's going on in China right now may want to consider these seven stocks we view as relatively safe from these woes.

Load More